Opening of meeting Copenhagen, Denmark September
|
|
- Arthur Prosper Black
- 5 years ago
- Views:
Transcription
1 Opening of meeting 1
2 Objectives of the meeting 1. To bring together a wide range of stakeholders whose combined efforts bring needed health products to vulnerable populations. 2. To sustain partnership, stimulate new exchanges and promote new partnerships 3. Provide updates from the WHO, UNICEF and UNFPA to stakeholders 4. Obtain feedback from stakeholders on: a) areas where things are going on well to be sustained b) areas that require improvement c) new areas of focus and innovation in the next year 5. Discuss issues that influence manufacturers participation in PQ: a) markets and value proposition of prequalified products and necessary investments b) Price consideration, determinants, sustainability and impact 2
3 Outline of the programme Day 1: Monday 18 Sept 2017 Session 1: Opening of meeting Venue: In auditorium I, II & III merged Scope: Key messages from WHO, UNICEF and UNFPA Session 2: A review of the markets for qualityassured products Venue: In auditorium I, II & III merged Scope: markets; prices; managing supply and shortages Session 3: How manufacturers can assess the value of quality-assured products Venue: In auditorium I, II & III merged Scope: Value proposition; stimulating introduction of new products Reception for all participants: Lounge area 9 3
4 Day 2: Tuesday 19 Sept 2017 Session 4: Procurement updates (Auditorium III) IVD prequalification for new applicants (Auditorium II) Introduction to vector control prequalification (Auditorium II) UNFPA / WHO contraceptive devices prequalification (Press Room) Session 5: Procurement updates Introduction to vaccines prequalification for new applicants WHO/UNFPA prequalification technical updates by product track Introduction to who pilot prequalification of biosimilars for cancer treatment Inspection updates Updates on technical assistance Updates on cold chain Improving traceability One to one meetings with PQT, Procurement agencies, Technical assistance and WHO collaborative procedure 4
5 Day 3: Wednesday, 20 September 2017 Session 6: Investing in WHO prequalification Venue: In auditorium I, II & III merged Scope: Reducing prequalification cost and maximizing opportunities Session 7: Getting products to markets promptly WHO collaborative registration & Caribbean regulatory system Venue: In auditorium I, II & III merged: Session 8: Prequalification feedback: open forum Venue: In auditorium I, II & III merged: One to one meetings with PQT, Procurement agencies, UNFPA, WHO collaborative procedure and Caribbean regulatory system 5
6 Day 4: Continuation of One to one meetings with PQT, Procurement agencies, UNFPA, WHO collaborative procedure and Caribbean regulatory system 6
7 Profile of participants Stakeholders whose combined efforts bring needed health products to vulnerable populations: manufacturers quality, safety and efficacy experts procurement agencies; and international donors Over 400 registered participants representing nearly 60 countries from all WHO regions. The 2017 meeting will cover not only vitro diagnostic products (IVDs), vaccines, finished pharmaceutical products, active pharmaceutical ingredients, and contraceptive devices, but also vector control products. 7
8 Opening meeting SESSION 1 IN AUDITORIUM I, II & III merged: OPENING OF MEETING Welcome address Given by: Emer Cooke, Head, Regulation of Medicines and other Health Technologies (WHO), 08:45 09:00 Suvi Rautio, Deputy Director, Supply Programme (UNICEF Supply Division); Eric Dupont, Chief, Procurement Services Branch (UNFPA) Administrative/security arrangements Given by: Jesper Palm 09:00 09:10 Lundorf (UN Office of the Designated Official for Security) 09:10 09:20 Introduction to meeting outline and app Deus Mubangizi and Mercedes Pérez González (WHO) 8
MONDAY, 18 SEPTEMBER. Day 1 07:30 09:00 MEETING REGISTRATION: ENTRANCE TO UN CITY. SESSION 1 IN AUDITORIUM I, II & III merged: OPENING OF MEETING
AGENDA JOINT, & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF CONTRACEPTIVE DEVICES, IN VITRO DIAGNOSTIC PRODUCTS, VACCINES, FINISHED PHARMACEUTICAL PRODUCTS, ACTIVE PHARMACEUTICAL INGREDIENTS AND VECTOR
More informationWhere the World is Going and What We Should do Next
Where the World is Going and What We Should do Next Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers of in vitro diagnostic products, vaccines, finished pharmaceutical products, active
More informationWHO Prequalification of in-vitro diagnostics, medicines and vaccines
WHO Prequalification of in-vitro diagnostics, medicines and vaccines Overview of prequalification processes & supporting activities Deus Mubangizi PQT Coordinator 20 October 2016 2 WHO prequalification
More informationTHIS IS UNFPA. Global Forum of Medical Devices Geneva 10 May 2017
THIS IS UNFPA Global Forum of Medical Devices Geneva 10 May 2017 World s largest public procurer of contraceptives RH commodities procured in 2016 over $146M $93.6M Contraceptives $34.9M Medical equipment
More informationWhere the World is Going and What We Should do Next
Where the World is Going and What We Should do Next Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers of in vitro diagnostic products, vaccines, finished pharmaceutical products, active
More informationWHO Prequalification Programmes
WHO Prequalification Programmes WHO Prequalification of Medicines Programme: survey of service quality provided to manufacturers Established in 2001, the Prequalification of Medicines Programme (PQP) is
More informationWHO Prequalification of Medicines Programme application fees
WHO Prequalification of Medicines Programme application fees This document explains the fees that apply to applications to prequalify medicines or active pharmaceutical ingredients and applications for
More informationSession 1: Prequalification and Procurement
Session 1: Prequalification and Procurement Session Objectives Discuss aims of the World Health Organization (WHO) Prequalification Programme Explain the role of the United Nations Population Fund (UNFPA)
More informationTransition to WHO-PQ. Vector control product evaluation. TITLE from VIEW and SLIDE MASTER 16 June 2016
Transition to WHO-PQ Vector control product evaluation 1 Key PQ activities to achieve transformation have been defined in the recently awarded grant 1 2 3 4 5 Improve quality and efficiency of vector control
More informationPrequalification Timeline Key Performance Indicators (KPIs)
1. Introduction The purpose of this document is to provide background information relating to prequalification (PQ) timeline indicators. It also covers harmonization of PQ timeline calculation, and the
More informationSession 2: Overview of the WHO Prequalification Programme for Condoms
Session 2: Overview of the WHO Prequalification Programme for Condoms Session Objectives Introduce the key differences between the new and old WHO/UNFPA prequalification scheme Understand the required
More informationCopenhagen, Denmark September A streamlined approach to the WHO Prequalification of In Vitro Diagnostics Programme: Overview
A streamlined approach to the WHO Prequalification of In Vitro Diagnostics Programme: Overview 1 Dept of Essential Medicines & Health Products: structure Essential Medicines and Health Product [EMP] Policy,
More informationModel Quality Assurance System for procurement agencies. What it means for manufacturers?
Model Quality Assurance System for procurement agencies. What it means for manufacturers? JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF DIAGNOSTIC PRODUCTS, FINISHED PHARMACEUTICAL
More informationVaccines assessment overview
Vaccines assessment overview 1 PQT WHO uses the same scientific principles to assess the products safety, quality and efficacy/performance as well-resourced national regulators: - scientific assessment
More informationWHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients WHO Prequalification Team (WHO-PQT)
More informationThe PQ (vaccines assessment) process mission, vision, objectives and stakeholders
The PQ (vaccines assessment) process mission, vision, objectives and stakeholders DCVMN meeting Sao Paulo UNICEF, Copenhagen 8-9 October 2014 Carmen Rodriguez Hernandez World Health Organization, EMP/RHT/PQT
More informationPrequalification of medicines
Prequalification of medicines Wondiyfraw Worku WHO Prequalification Team 3.2.S.3.2 Impurities, Malaysia, 1 29 September 2011 CPHI Mumbai 2017 1 Background In early 2000, there was an increasing demand
More informationTechnical Guidance and Specifications
Technical Guidance and Specifications Deirde Healy and Robyn Meurant WHO PQ Team Diagnostics Assessment Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers of in vitro diagnostics, vaccines,
More informationSession 1 in Auditorium II: Product priorities for development and procurement
PROVISIONAL AGENDA JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF DIAGNOSTIC PRODUCTS, VACCINES, FINISHED PHARMACEUTICAL PRODUCTS AND ACTIVE PHARMACEUTICAL INGREDIENTS 22 25 September
More informationWHO Prequalification Team Vector Control Products Assessment Group
WHO Prequalification Team Vector Control Products Assessment Group Workshop on Dossier Requirements and Proposed Inspection Protocol 26-28 October 2016, Geneva, Switzerland 1 Recall: WHO leadership is
More informationWorld Bank Training Program on HIV/AIDS Drugs
World Bank Training Program on HIV/AIDS Drugs Training Module 4 Quality Assurance PART 2 based on the World Bank document Battling HIV/AIDS: A Decision Maker s Guide to the Procurement of Medicines and
More informationSession 1 in Auditorium II: Product priorities for development and procurement
PROVISIONAL AGENDA JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF DIAGNOSTIC PRODUCTS, VACCINES, FINISHED PHARMACEUTICAL PRODUCTS AND ACTIVE PHARMACEUTICAL INGREDIENTS 22 25 September
More informationThe Expert Review Panel for Diagnostics
The Expert Review Panel for Diagnostics JOINT UNICEF, UNFPA & WHO meeting with manufacturers, Copenhagen 22-24 Sep 2014 Dr Joelle DAVIAUD Quality Assurance Officer The Global Fund ERPD mechanism Sept 2014
More informationWHO Prequalification of in-vitro diagnostics, medicines, vaccines and vector control products
WHO Prequalification of in-vitro diagnostics, medicines, vaccines and vector control products Overview of prequalification processes & product-specific updates Deus Mubangizi Coordinator, WHO Prequalification
More informationWHO Prequalification of in-vitro diagnostics, medicines, vaccines and vector control products
WHO Prequalification of in-vitro diagnostics, medicines, vaccines and vector control products Overview of prequalification processes & product-specific updates Deus Mubangizi Coordinator, WHO Prequalification
More informationWHO Prequalification of Diagnostics Regulatory
WHO Prequalification of Diagnostics Regulatory Dr Lembit Rägo Head, Regulation of Medicines and other Health Technologies Essential Medicines and Health Products Essential Medicines and Health Products
More informationProcurement and Quality Assurance Updates
Procurement and Quality Assurance Updates Joint meeting UNICEF, WHO, UNFPA with manufacturers and suppliers 19 September 2017 Sophie Logez, Health Product Management Hub Outline Overview of the Global
More informationWHO Update. Mike Ward Department of Essential Medicines and Health Products
WHO Update Mike Ward Department of Essential Medicines and Health Products PQ Statistics WHO PREQUALIFICATION STATISTICS 2015 2016 2017 No of applications 22 65 20 No of new manufacturers 3 5 19 No Prequalified
More informationAction points and notes. UNFPA, UN House, Copenhagen Denmark
Action points and notes IPC Meeting 30 th November 02 nd December 2011 UNFPA, UN House, Copenhagen Denmark Action points - Share draft documents on diagnostics to be shared with IPC members for review
More informationWHO support and Technical Assistance _ In-Vitro Diagnostics
WHO support and Technical Assistance _ In-Vitro Diagnostics Joint UNICEF, UNFPA & WHO Meeting with Manufacturers and suppliers UN City, Copenhagen, Denmark 24-27 September 2018 Dr Gaby Vercauteren Senior
More informationRegulatory system strengthening
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/32 Provisional agenda item 15.6 14 March 2014 Regulatory system strengthening Report by the Secretariat 1. The Executive Board at its 134th session noted an earlier
More informationUNFPA s Procurement Services Branch (PSB)
UNFPA s Procurement Services Branch (PSB) UNFPA Supplier Workshop, September 2013 Agenda 1. PSB in Copenhagen what we do & who we are 2. What UNFPA procures 2012 statistics 3. Procurement Principles &
More informationSession 5: Increase in Use of the WHO Prequalification Programme
Session 5: Increase in Use of the WHO Prequalification Programme Perceived Need for Prequalification In an ideal world: Regulated pharmacies and service providers would supply medicines to clients Regulatory
More informationPre- ICDRA Exhibition Guide
Pre- ICDRA Exhibition Guide Invitation to Exhibit at PRE- ICDRA 3-4 September 2018 The HPRA is honoured to have been selected by the World Health Organization (WHO) to host delegates from each of the WHO
More informationAPI Assessment Activities. Antony Fake, PhD
API Assessment Activities Antony Fake, PhD 2 Overview APIMF Procedure API PQ Procedure What is new? 3 Abbreviations API Active Pharmaceutical Ingredient FPP Finished Pharmaceutical Product API PQ API Prequalification
More informationWorld s largest public procurer of contraceptives
THIS IS UNFPA World s largest public procurer of contraceptives RH commodities procured in 2016 over $146M $93.6M Contraceptives $34.9M Medical equipment $17.5M Pharmaceuticals In 2016, UNFPA delivered
More informationAPI Assessment Activities
API Assessment Activities Antony Fake PhD WHO Medicines Prequalification Programme 1 3.2.S.3.2 Impurities, Malaysia, 29 September 2011 2 Overview APIMF Procedure API PQ Procedure What is new? 3 Abbreviations
More informationJoint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients Copenhagen, Denmark 23 26 November
More informationWHO Pre-Qualification Programme: Facilitating Regional Approval and Patient Access to Treatments
WHO Pre-Qualification Programme: Facilitating Regional Approval and Patient Access to Treatments A Decade of R&D for Neglected Diseases in Africa Nairobi, Kenya, 4-5 June 2013 Hiiti B. Sillo Director General
More informationIntroduction to Inspections. Dr Joey Gouws PQT Group Lead: Inspections Regulation of Medicines and other Health Technologies
Introduction to Inspections Dr Joey Gouws PQT Group Lead: Inspections Regulation of Medicines and other Health Technologies 1 Index Introduction DG message PQT: Inspections Scope Experience: National v
More informationProcurement Services Branch
Procurement Services Branch Delivering supplies for reproductive health results Madrid Business Seminar 28 th November, 2016 UNFPA s mandate Procurement Services Branch - PSB Delivering supplies for reproductive
More informationRegulatory capacity building and NDRA approvals of prequalified products
Regulatory capacity building and NDRA approvals of prequalified products Milan Smid WHO Prequalification Team Principal objective of PQP capacity building: To facilitate availability of quality priority
More informationPatients are waiting: How regulators collectively make a difference Present challenges and opportunities - roadmap for the future
ICDRA 17 th International Conference of Drug Regulatory Authorities Patients are waiting: How regulators collectively make a difference Present challenges and opportunities - roadmap for the future The
More informationPROMOTING ACCESS, QUALITY AND INNOVATION TO SAVE AND IMPROVE LIVES
PROMOTING ACCESS, QUALITY AND INNOVATION TO SAVE AND IMPROVE LIVES Essential Medicines and Health Products 2 VISION: A WORLD WHERE EVERY CHILD, MAN AND WOMAN CAN AFFORD AND HAS ACCESS TO THE QUALITY ESSENTIAL
More informationRevised Global Fund Quality Assurance Policy for Pharmaceutical Products and Price &Quality Reporting
Revised Global Fund Quality Assurance Policy for Pharmaceutical Products and Price &Quality Reporting AIDS Medicines and Diagnostics Services (AMDS) Partners and Stakeholders Meeting, Board Decision on
More informationSPONSORSHIP BROCHURE
SPONSORSHIP BROCHURE TABLE OF CONTENTS 03 Welcome introduction 04 General presentation 05 Why become a sponsor? 06 Major Partnerships 08 Opportunities available to major partners only 10 Exhibition packages
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme TB Alliance Open Forum 4 Key Issues in TB Drug Development Wondiyfraw Z. Worku Technical officer August 18-19, 2010 Addis Ababa, Ethiopia Out line Brief intro to
More informationCollaborative Procedure to Accelerate Medicines Registration
Collaborative Procedure to Accelerate Medicines Registration Pharmaceuticals Limited Mumbai, INDIA Challenging the Frontiers in Healthcare Outline Introduction to Macleods Pharma. Regulatory filings by
More informationReport on meetings of expert committees and study groups 1
EXECUTIVE BOARD EB137/9 137th session 27 March 2015 Provisional agenda item 10 Report on meetings of expert committees and study groups 1 Report by the Secretariat SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS
More informationWHO-UNICEF-UNFPA Meeting Copenhagen November 2015
WHO-UNICEF-UNFPA Meeting Copenhagen November 2015 Quality Assessment: Updates Lynda Paleshnuik Lead Quality Assessor 1 Overview Submitting your dossier Before you submit WHO publications and PQ quality
More informationQuality Quality problems r API used used in essent essen ial t ial medicines : Role e of of WHO and and its its pre pr lifi qua ca i ttion on progr
Quality problems for API used in essential medicines : Role of WHO and its pre qualification programme Corinne POUGET Consultant Pavia 11 May 2012 1 A few key figures 2010 WW Pharmaceutical market: a USD
More informationCost-effective Purification of Vaccines, Data Integrity Systems and CTDs. DRAFT AGENDA Rio de Janeiro, 18 to 20 June 2018
Cost-effective Purification of Vaccines, Data Integrity Systems and CTDs DRAFT AGENDA Rio de Janeiro, 18 to 20 June 2018 DAY1, Monday 18 June - Welcome & Introduction Plenary session for all participants
More informationRole of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval
Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval UN Prequalification of Medicines, Diagnostics and Vaccines 6 th Consultative Stakeholder Meeting 4 April
More informationWHO Prequalification of Medicines Programme (WHO-PQP): Ensuring quality medicines
WHO Prequalification of Medicines Programme (WHO-PQP): Ensuring quality medicines Dr Lembit Rägo Essential Medicines and Health Products World Health Organization Geneva Switzerland ragol@who.int 1 Context
More informationLas Vegas. Palms Casino Resort, Las Vegas icmi.com/lasvegas Sept 23-26, 2014
Las Vegas Palms Casino Resort, Las Vegas icmi.com/lasvegas 800.672.6177 Sept 23-26, 2014 Contact Center Training to Improve Performance If you re a call center professional looking to enhance your knowledge,
More informationActive pharmaceutical ingredients update. Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers- September 2014
Active pharmaceutical ingredients update. Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers- September 2014 Isabel Ortega-Antony Fake WHO Prequalification Team-Medicines 1 Reminder The
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationWHO Prequalification of In Vitro Diagnostics
WHO Prequalification of In Vitro Diagnostics 3 rd WHO Global Forum on Medical Devices Geneva, 10 May 2017 Helena Ardura & Deirdre Healy WHO PQ Team Diagnostics Assessment Essential Medicines and Health
More informationProcurement Services Branch
Procurement Services Branch Delivering supplies for reproductive health results Nordic Business Seminar June 15-16, 2016 UNFPA s mandate Procurement Services Branch - PSB Delivering supplies for reproductive
More informationPROGRAMME. 16:00 20:30 Hotel NH Constanza, Carrer de Deu i Mata Barcelona, Spain Tel
UNITED NATIONS 2010 UNITED NATIONS PUBLIC SERVICE DAY AWARDS CEREMONY AND FORUM ON THE ROLE OF PUBLIC SERVICE IN ACHIEVING THE MILLENNIUM DEVELOPMENT GOALS: CHALLENGES AND BEST PRACTICES 21-23 June 2010
More informationGDF, the Global mechanism to facilitate access to affordable quality assured TB medicines and diagnostics, including new tools
The Global Drug Facility (GDF) GDF, the Global mechanism to facilitate access to affordable quality assured TB medicines and diagnostics, including new tools Magali Babaley Strategic Procurement and Business
More informationGood Procurement Practices for artemisinin-based antimalarial medicines
Good Procurement Practices for artemisinin-based antimalarial medicines AMDS Partners and Stakeholders Meeting Geneva, 23 March 2010 Silvia Schwarte Medicines and Diagnostics Unit Global Malaria Programme
More informationRegulatory system strengthening for medical products
EXECUTIVE BOARD 134th session 23 January 2014 Agenda item 9.5 Regulatory system strengthening for medical products Draft resolution proposed by Australia, Colombia, Mexico, Nigeria, South Africa, Switzerland
More informationWHO updates on Regulatory System Strengthening and Prequalification activities
WHO updates on Regulatory System Strengthening and Prequalification activities UNICEF 2016 CONSULTATION WITH VACCINE INDUSTRY Copenhagen, 15 and 16 November 2016 Mike Ward and Alireza Khadem Regulatory
More informationWHO-PQP GMP Inspections: Updates
JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF DIAGNOSTIC PRODUCTS, FINISHED PHARMACEUTICAL PRODUCTS AND ACTIVE PHARMACEUTICAL INGREDIENTS 23 25 September 2013, Copenhagen, Denmark
More informationQuality assurance for essential medicines and health products. IPC meeting: December 2012
Quality assurance for essential and health products IPC meeting: December 2012 Pharmaceutical Products QA Policy (June 2009) December 2010: requirements to purchase ACTs FDC in priority Condoms Procurement
More informationUpdate of the procedure for WHO vaccines prequalification by Dr. Nora Dellepiane,
Update of the procedure for WHO vaccines prequalification by Dr. Nora Dellepiane, Manager Vaccines Prequalification Programme Prequalification Stakeholders meeting Geneva 4 and 5 April 2011, Switzerland
More informationJoint WQHO/UNICEF/UNFPA suppliers meeting
Joint WQHO/UNICEF/UNFPA suppliers meeting Pre-qualification of male latex condoms Tuesday 24 th November 2015 David Hill David Hill and Associates Pre-qualification of manufacturing sites UNFPA inspector
More informationWednesday October 14, Invitation only. For more information, please visit
Wednesday October 14, 2015 Startup Acceleration Training (8:00-15:00) Sponsored by: 08:00-15:00 Invitation only. For more information, please visit http://goo.gl/forms/fpm0vdyciz. Biocluster Workshop -
More informationUNITED NATIONS POPULATION FUND. Integrated budget, Annex I Cost recovery - detailed information based on current cost recovery methodology
UNITED NATIONS POPULATION FUND Integrated budget, 2018-2021 Annex I Cost recovery - detailed information based on current cost recovery methodology Summary The present document provides detailed descriptions
More informationPROPOSAL FOR UPDATING THE DEFINITION OF STRINGENT REGULATORY AUTHORITY
August 2017 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 PROPOSAL FOR UPDATING THE DEFINITION OF World Health Organization
More informationROLE OF RELIANCE, RE-ENGINEERING, AND REGIONALIZATION IN THE OPTIMIZATION OF REGULATORY SYSTEMS
ROLE OF RELIANCE, RE-ENGINEERING, AND REGIONALIZATION IN THE OPTIMIZATION OF REGULATORY SYSTEMS Murray M. Lumpkin, M.D., M.Sc. Lead for Global Regulatory Systems Initiatives Bill and Melinda Gates Foundation
More informationSession 13: Prequalification Within the Context of Global Fund Procurements
Session 13: Prequalification Within the Context of Global Fund Procurements Established in 2002 Global Fund Attracts and disburses additional resources to prevent and treat AIDS, tuberculosis (TB), and
More informationWHO Prequalification of Medicines Programme
WHO Prequalification of Medicines Programme Ensuring quality medicines: a decade of prequalification Reflections from A. J. van Zyl, First Programme Manager for the In March 2001, United Nations partners
More informationSecond Africa TB Regional Conference on Management of TB Medicines. Africa TB Conference 2012, Zanzibar December 5-7, 2012
Second Africa TB Regional Conference on Management of TB Medicines Africa TB Conference 2012, Zanzibar December 5-7, 2012 Assuring the Quality of Medicines Abdelkrim Smine, Ph.D. Promoting the Quality
More informationSponsorship Prospectus
Sponsorship Prospectus TRADE SHOW & CONFERENCE OCTOBER 13-16 THE WESTIN BOSTON WATERFRONT chauffeurdrivenshow.com Title (3 Available) $25,000 This top-level sponsorship opportunity delivers the most exposure
More informationInnovation to Impact WHO change plan on evaluation of pesticides Malaria Policy Advisory Committee Geneva, Switzerland September 2015
Innovation to Impact WHO change plan on evaluation of pesticides Malaria Policy Advisory Committee Geneva, Switzerland 16-18 September 2015 Raman Velayudhan and Abraham Mnzava 0 WHO leadership is strongly
More informationRegulation, Norms and Standards for medical products *
Regulation, Norms and Standards for medical products * Technical Briefing Seminar 23-27 November, 2015 Dr Lembit Rägo Head, Regulation of Medicines and other Health Technologies Essential Medicines and
More informationCurrent Situation of Regulations and Premarket Review in Future of Companion Diagnostics in Japan
Current Situation of Regulations and Premarket Review in Future of Companion Diagnostics in Japan Daisei Miyamoto Pharmaceuticals and Medical Devices Agency(PMDA) Review Director, Office of Medical Devices
More informationINTER CHANGEABILITY and EQUIVALENCE. Where we are and what we still have to determine!
INTER CHANGEABILITY and EQUIVALENCE Where we are and what we still have to determine! Acknowledgement Joint presentation UNICEF/MSF/ICRC Cecile Mace Jean Michel Caudron Birgit Schmauser What do we mean
More informationWHO Medicines Prequalification Bioequivalence Assessment Update
WHO Medicines Prequalification Bioequivalence Assessment Update Dr. John Gordon 1 Overview Bioequivalence (BE) guidelines In vivo bioequivalence study designs Approaches for addressing unknown/high variability
More informationPharmaceutical Quality System (PQS)
Implementation of ICH Q8, Q9, Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Structure of
More informationGS1 African Healthcare Conference
GS1 African Healthcare Conference Traceability and verification of anti-malarial commodities in the Ethiopian supply chain Teddy Berihun, Senior Health Information Systems Adviser USAID, Ethiopia Al Shiferaw,
More informationWednesday October 14, Invitation only. For more information, please visit
Wednesday October 14, 2015 Startup Acceleration Training (8:00-15:00) 08:00-15:00 Invitation only. For more information, please visit http://goo.gl/forms/fpm0vdyciz. Biocluster Workshop - Internationalization
More informationFund Council. 10 th Meeting (FC10) Nairobi, Kenya November 6-7, GCARD3 Funding Proposal. (Working Document - For Discussion Only)
Fund Council 10 th Meeting (FC10) Nairobi, Kenya November 6-7, 2013 GCARD3 Funding Proposal (Working Document - For Discussion Only) Document presented for Agenda Item 5: Governance Matters Submitted by:
More informationUpdate on China-Denmark Food and Drug Regulatory Cooperation Centre
Update on China-Denmark Food and Drug Regulatory Cooperation Centre Stakeholder meeting, 7 December 2017 Jakob Cold, Deputy Director General State of Play China-Denmark Drug Administrative Law Exchange
More informationProgramme update WHO Prequalification of Diagnostics
Prequalification of Medicines, Diagnostics and Vaccines h Consultative Stakeholders Meeting, Geneva, 4 April 2011 Programme update WHO Prequalification of Diagnostics Dr Gaby Vercauteren Diagnostics and
More information1 Public Policy Analysis & Management And Project Cycle Management Staff Training Programme
1 Public Policy Analysis & Management And Project Cycle Management Staff Training Programme 2 Public Policy Analysis & Management And Project Cycle Management Staff Training Programme FOREWORD Dear Colleagues,
More informationContents APEC Harmonization Center(AHC)
Contents APEC Harmonization Center(AHC) I. AHC- A Brief Overview II. Inauguration Ceremony of AHC III. Multi-Regional Clinical Trial Workshop IV. Biosimilar Workshop V. Next Steps AHC Vision Establishment
More informationSafe Injection Equipment
Safe Injection Equipment Industry Consultation 21 st 22 nd April 2015 Overview of UNICEF procurement of Safe Injection Equipment Rob Matthews, HTC Objective of Session Provide an overview of UNICEFs engagement
More informationICH Q10/WHO TRS A Regulatory Perspective
Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique
More informationGENERAL GUIDELINES FOR COLD CHAIN EQUIPMENT
SUPPLY DIVISION COLD CHAIN SUPPORT PACKAGE PROCUREMENT GUIDELINES GENERAL GUIDELINES FOR COLD CHAIN EQUIPMENT Procurement Guidelines General Guidelines for Cold Chain Equipment Key information for UNICEF
More informationEMA / FDA efforts towards Regulatory Harmonisation - Transatlantic Trade and Investment Partnership (TTIP)
EMA / FDA efforts towards Regulatory Harmonisation - Transatlantic Trade and Investment Partnership (TTIP) European Health Forum - 3 rd October 2013 Falk Ehmann MD, PhD European Medicines Agency - London
More informationUNICEF s Supply Function Nutrition Suppliers Meeting June 2017
UNICEF s Supply Function Nutrition Suppliers Meeting 14-15 June 2017 Critical functions of Supply Division Support results for children with an effective, efficient supply operation Help meet UNICEF s
More informationIntroduction of new suppliers to UNICEF procurement mechanisms
UNICEF/PFPG2015-2253/Lynch Introduction of new suppliers to UNICEF procurement mechanisms Vaccine Industry Consultation 2017 Outline Supplier Registration Supplier Performance Monitoring Requirements for
More informationSAPRAA Meeting Alternative API evaluation processes e.g. Confirmation of WHO API Prequalification - CPQ
SAPRAA Meeting Alternative API evaluation processes e.g. Confirmation of WHO API Prequalification - CPQ Silverani Padayachee O303030 October 201530 30 October 2015 Bytes Conference Centre-Midrand Alternative
More informationBuilding Systems for Access and Appropriate Use of iccm Medicines
Building Systems for Access and Appropriate Use of iccm Medicines Jane Briggs SIAPS, Arlington, VA, USA with Beth Yeager and Suzanne Diarra Global Health Mini University Washington, DC March 4, 2016 Objectives
More informationDay 1. Preliminary Agenda April 24-26, Tuesday, April 24th Hard Rock Hotel Las Vegas, NV 7:00AM - 8:00AM. Registration
Day 1 Tuesday, April 24th Hard Rock Hotel Las Vegas, NV 7:00AM - 8:00AM Registration Registration Desk Opens Monday, April 23rd @ 2:00 PM 8:00AM - 12:00PM JAGGAER University JAGGAER University is offering
More information